Targeted delivery to the nucleus

Advanced Drug Delivery Reviews

Volumn 59, Issue 8, 2007, Pages 698-717

  Pouton, Colin W ^a   Wagstaff, Kylie M ^b   Roth, Daniela M ^a,b   Moseley, Gregory W ^b   Jans, David A ^b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Dynein; Gene delivery systems; Importins; Intracellular trafficking; Microtubular trafficking; Non viral gene therapy; Nuclear import; Nuclear pore complex; Viral transport

Indexed keywords

CELLS; GENES; MACROMOLECULES; VIRUSES;

GENE DELIVERY SYSTEMS; INTRACELLULAR TRAFFICKING; MICROTUBULAR TRAFFICKING; NON VIRAL GENE THERAPY; NUCLEAR IMPORT; NUCLEAR PORE COMPLEX; VIRAL TRANSPORT;

DRUG DELIVERY;

ADENOVIRUS VECTOR; DNA; DNA BINDING PROTEIN; HERPESVIRUS VECTOR; HIGH MOBILITY GROUP B PROTEIN; HISTONE; HYBRID PROTEIN; LENTIVIRUS VECTOR; NUCLEIC ACID; PARVOVIRUS VECTOR; VIRUS VECTOR;

ACTIVE TRANSPORT; APOPTOSIS; BINDING AFFINITY; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL TYPE; CYTOSKELETON; DNA BINDING; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOSOME; GENE EXPRESSION; GENE THERAPY; HUMAN; MICROTUBULE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONVIRAL GENE THERAPY; NUCLEAR PORE COMPLEX; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

ACTIVE TRANSPORT, CELL NUCLEUS; BIOLOGICAL TRANSPORT; CELL NUCLEUS; CYTOPLASM; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; KARYOPHERINS; MICROTUBULES; MODELS, BIOLOGICAL; NUCLEAR EXPORT SIGNALS; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PORE; NUCLEAR PORE COMPLEX PROTEINS; PROTEIN TRANSPORT; RAN GTP-BINDING PROTEIN; VIRAL PHYSIOLOGY;

EID: 34548231919     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.06.010     Document Type: Review

References (232)

1. Robbins P.D., and Ghivizzani S.C. Viral vectors for gene therapy. Pharmacol. Ther. 80 (1998) 35-47
2. Glover D.J., Lipps H.J., and Jans D.A. Towards safe, non-viral therapeutic gene expression in humans. Nat. Rev., Genet. 6 (2005) 299-310
3. Capecchi M.R. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22 (1980) 479-488
4. Dowty M.E., Williams P., Zhang G., Hagstrom J.E., and Wolff J.A. Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4572-4576
5. Feldherr C.M. The nuclear annuli as pathways for nucleocytoplasmic exchanges. J. Cell Biol. 14 (1962) 65-72
6. Harel A., and Forbes D.J. Importin beta: conducting a much larger cellular symphony. Mol. Cell 16 (2004) 319-330
7. Wente S.R. Gatekeepers of the nucleus. Science 288 (2000) 1374-1377
8. Stoffler D., Feja B., Fahrenkrog B., Walz J., Typke D., and Aebi U. Cryo-electron tomography provides novel insights into nuclear pore architecture: implications for nucleocytoplasmic transport. J. Mol. Biol. 328 (2003) 119-130
9. Talcott B., and Moore M.S. Getting across the nuclear pore complex. Trends Cell Biol. 9 (1999) 312-318
10. Ribbeck K., and Gorlich D. Kinetic analysis of translocation through nuclear pore complexes. EMBO J. 20 (2001) 1320-1330
11. Poon I.K., and Jans D.A. Regulation of nuclear transport: central role in development and transformation?. Traffic 6 (2005) 173-186
12. Rout M.P., and Aitchison J.D. The nuclear pore complex as a transport machine. J. Biol. Chem. 276 (2001) 16593-16596
13. Goldfarb D.S., Corbett A.H., Mason D.A., Harreman M.T., and Adam S.A. Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol. 14 (2004) 505-514
14. Gorlich D., Henklein P., Laskey R.A., and Hartmann E. A 41 amino acid motif in importin-alpha confers binding to importin-beta and hence transit into the nucleus. EMBO J. 15 (1996) 1810-1817
15. Kobe B. Autoinhibition by an internal nuclear localization signal revealed by the crystal structure of mammalian importin alpha.[see comment]. Nat. Struct. Biol. 6 (1999) 388-397
16. Chook Y.M., and Blobel G. Karyopherins and nuclear import. Curr. Opin. Struct. Biol. 11 (2001) 703-715
17. Bayliss R., Littlewood T., and Stewart M. Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking. Cell 102 (2000) 99-108
18. Kutay U., Izaurralde E., Bischoff F.R., Mattaj I.W., and Gorlich D. Dominant-negative mutants of importin-beta block multiple pathways of import and export through the nuclear pore complex. EMBO J. 16 (1997) 1153-1163
19. Bayliss R., Corbett A.H., and Stewart M. The molecular mechanism of transport of macromolecules through nuclear pore complexes. Traffic 1 (2000) 448-456
20. Azuma Y., and Dasso M. The role of Ran in nuclear function. Curr. Opin. Cell Biol. 12 (2000) 302-307
21. Melchior F., and Gerace L. Two-way trafficking with Ran. Trends Cell Biol. 8 (1998) 175-179
22. Vetter I.R., Nowak C., Nishimoto T., Kuhlmann J., and Wittinghofer A. Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport. Nature 398 (1999) 39-46
23. Ribbeck K., Lipowsky G., Kent H.M., Stewart M., and Gorlich D. NTF2 mediates nuclear import of Ran. EMBO J. 17 (1998) 6587-6598
24. Smith A., Brownawell A., and Macara I.G. Nuclear import of Ran is mediated by the transport factor NTF2. Curr. Biol. 8 (1998) 1403-1406
25. Jakel S., Albig W., Kutay U., Bischoff F.R., Schwamborn K., Doenecke D., and Gorlich D. The importin beta/importin 7 heterodimer is a functional nuclear import receptor for histone H1. EMBO J. 18 (1999) 2411-2423
26. Lam M.H., Briggs L.J., Hu W., Martin T.J., Gillespie M.T., and Jans D.A. Importin beta recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin alpha. J. Biol. Chem. 274 (1999) 7391-7398
27. Langer T. Nuclear transport of histone 2b in mammalian cells is signal-and energy-dependent and different from the importin alpha/beta-mediated process. Histochem. Cell Biol. 113 (2000) 455-465
28. Mosammaparast N., Guo Y., Shabanowitz J., Hunt D.F., and Pemberton L.F. Pathways mediating the nuclear import of histones H3 and H4 in yeast. J. Biol. Chem. 277 (2002) 862-868
29. Pollard V.W., Michael W.M., Nakielny S., Siomi M.C., Wang F., and Dreyfuss G. A novel receptor-mediated nuclear protein import pathway. Cell 86 (1996) 985-994
30. Wagstaff K.M., Glover D.J., Tremethick D.J., and Jans D.A. Histone-mediated Transduction as an Efficient Means for Gene Delivery. Molec. Ther. 15 (2007) 721-731
31. Xiao Z., Liu X., and Lodish H.F. Importin beta mediates nuclear translocation of Smad 3. J. Biol. Chem. 275 (2000) 23425-23428
32. Chan C.K., and Jans D.A. Using nuclear targeting signals to enhance non-viral gene transfer. Immunol. Cell Biol. 80 (2002) 119-130
33. Gorlich D., and Kutay U. Transport between the cell nucleus and the cytoplasm. Ann. Rev. Cell Dev. Biol. 15 (1999) 607-660
34. van der Aa M.A., Mastrobattista E., Oosting R.S., Hennink W.E., Koning G.A., and Crommelin D.J. The nuclear pore complex: the gateway to successful nonviral gene delivery. Pharm. Res. 23 (2006) 447-459
35. Jans D.A., Chan C.K., and Huebner S. Signals mediating nuclear targeting and their regulation: application in drug delivery. Med. Res. Rev. 18 (1998) 189-223
36. Kalderon D., Richardson W.D., Markham A.F., and Smith A.E. Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature 311 (1984) 33-38
37. Kalderon D., Roberts B.L., Richardson W.D., and Smith A.E. A short amino acid sequence able to specify nuclear location. Cell 39 (1984) 499-509
38. Chan C.K., and Jans D.A. Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence. Hum. Gene Ther. 10 (1999) 1695-1702
39. Chan C.K., and Jans D.A. Enhancement of MSH receptor-and GAL4-mediated gene transfer by switching the nuclear import pathway. Gene Ther. 8 (2001) 166-171
40. Robbins J., Dilworth S.M., Laskey R.A., and Dingwall C. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64 (1991) 615-623
41. Hall M.N., Craik C., and Hiraoka Y. Homeodomain of yeast repressor alpha 2 contains a nuclear localization signal. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 6954-6958
42. Hall M.N., Hereford L., and Herskowitz I. Targeting of E. coli beta-galactosidase to the nucleus in yeast. Cell 36 (1984) 1057-1065
43. Chan C.K., Hubner S., Hu W., and Jans D.A. Mutual exclusivity of DNA binding and nuclear localization signal recognition by the yeast transcription factor GAL4: implications for nonviral DNA delivery. Gene Ther. 5 (1998) 1204-1212
44. Tiganis T., Flint A.J., Adam S.A., and Tonks N.K. Association of the T-cell protein tyrosine phosphatase with nuclear import factor p97. J. Biol. Chem. 272 (1997) 21548-21557
45. Forwood J.K., Lam M.H., and Jans D.A. Nuclear import of Creb and AP-1 transcription factors requires importin-beta 1 and Ran but is independent of importin-alpha. Biochemistry (Mosc.) 40 (2001) 5208-5217
46. Forwood J.K., Harley V., and Jans D.A. The C-terminal nuclear localization signal of the sex-determining region Y (SRY) high mobility group domain mediates nuclear import through importin beta 1. J. Biol. Chem. 276 (2001) 46575-46582
47. Johnson-Saliba M., Siddon N.A., Clarkson M.J., Tremethick D.J., and Jans D.A. Distinct importin recognition properties of histones and chromatin assembly factors. FEBS Lett. 467 (2000) 169-174
48. Cingolani G., Bednenko J., Gillespie M.T., and Gerace L. Molecular basis for the recognition of a nonclassical nuclear localization signal by importin beta. Mol. Cell 10 (2002) 1345-1353
49. Sekimoto T., Imamoto N., Nakajima K., Hirano T., and Yoneda Y. Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1. EMBO J. 16 (1997) 7067-7077
50. Miyamoto Y., Imamoto N., Sekimoto T., Tachibana T., Seki T., Tada S., Enomoto T., and Yoneda Y. Differential modes of nuclear localization signal (NLS) recognition by three distinct classes of NLS receptors. J. Biol. Chem. 272 (1997) 26375-26381
51. Kohler M., Speck C., Christiansen M., Bischoff F.R., Prehn S., Haller H., Gorlich D., and Hartmann E. Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import. Mol. Cell. Biol. 19 (1999) 7782-7791
52. Hu W., and Jans D.A. Efficiency of importin alpha/beta-mediated nuclear localization sequence recognition and nuclear import. Differential role of NTF2. J. Biol. Chem. 274 (1999) 15820-15827
53. Hubner S., Smith H.M., Hu W., Chan C.K., Rihs H.P., Paschal B.M., Raikhel N.V., and Jans D.A. Plant importin alpha binds nuclear localization sequences with high affinity and can mediate nuclear import independent of importin beta. J. Biol. Chem. 274 (1999) 22610-22617
54. Marg A., Shan Y., Meyer T., Meissner T., Brandenburg M., and Vinkemeier U. Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1. J. Cell Biol. 165 (2004) 823-833
55. Hogarth C., Itman C., Jans D.A., and Loveland K.L. Regulated nucleocytoplasmic transport in spermatogenesis: a driver of cellular differentiation?. BioEssays 27 (2005) 1011-1025
56. Hogarth C.A., Calanni S., Jans D.A., and Loveland K.L. Importin alpha mRNAs have distinct expression profiles during spermatogenesis. Dev. Dyn. 235 (2006) 253-262
57. Fang X., Chen T., Tran K., and Parker C.S. Developmental regulation of the heat shock response by nuclear transport factor karyopherin-alpha3. Development 128 (2001) 3349-3358
58. Nachury M.V., Ryder U.W., Lamond A.I., and Weis K. Cloning and characterization of hSRP1 gamma, a tissue-specific nuclear transport factor. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 582-587
59. Kohler M., Ansieau S., Prehn S., Leutz A., Haller H., and Hartmann E. Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family. FEBS Lett. 417 (1997) 104-108
60. Sherr C.J. Principles of tumor suppression. Cell 116 (2004) 235-246
61. Kau T.R., Way J.C., and Silver P.A. Nuclear transport and cancer: from mechanism to intervention. Nat. Rev., Cancer 4 (2004) 106-117
62. Kim I.S., Kim D.H., Han S.M., Chin M.U., Nam H.J., Cho H.P., Choi S.Y., Song B.J., Kim E.R., Bae Y.S., and Moon Y.H. Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53. J. Biol. Chem. 275 (2000) 23139-23145
63. Jans D.A., Xiao C.Y., and Lam M.H. Nuclear targeting signal recognition: a key control point in nuclear transport?. BioEssays 22 (2000) 532-544
64. Smith W.A., Schurter B.T., Wong-Staal F., and David M. Arginine methylation of RNA helicase a determines its subcellular localization. J. Biol. Chem. 279 (2004) 22795-22798
65. Thevenet L., Mejean C., Moniot B., Bonneaud N., Galeotti N., Aldrian-Herrada G., Poulat F., Berta P., Benkirane M., and Boizet-Bonhoure B. Regulation of human SRY subcellular distribution by its acetylation/deacetylation. EMBO J. 23 (2004) 3336-3345
66. Nikolaev A.Y., Li M., Puskas N., Qin J., and Gu W. Parc: a cytoplasmic anchor for p53. [see comment]. Cell 112 (2003) 29-40
67. Tago K., Tsukahara F., Naruse M., Yoshioka T., and Takano K. Regulation of nuclear retention of glucocorticoid receptor by nuclear Hsp90. Mol. Cell. Endocrinol. 213 (2004) 131-138
68. Roth D.M., Moseley G.W., Glover D.J., Pouton C.W., and Jans D.A. A microtubule-facilitated nuclear import pathway for cancer regulatory proteins. Traffic 8 (2007) 673-686
69. Riviere Y., Blank V., Kourilsky P., and Israel A. Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection. Nature 350 (1991) 625-626
70. Beals C.R., Clipstone N.A., Ho S.N., and Crabtree G.R. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev. 11 (1997) 824-834
71. Kaffman A., Rank N.M., and O'Shea E.K. Phosphorylation regulates association of the transcription factor Pho4 with its import receptor Pse1/Kap121. Genes Dev. 12 (1998) 2673-2683
72. Beg A.A., Ruben S.M., Scheinman R.I., Haskill S., Rosen C.A., and Baldwin Jr. A.S. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.[erratum appears in Genes Dev 1992 Dec;6(12B):2664-5]. Genes Dev. 6 (1992) 1899-1913
73. Traenckner E.B., Wilk S., and Baeuerle P.A. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13 (1994) 5433-5441
74. Asada M., Ohmi K., Delia D., Enosawa S., Suzuki S., Yuo A., Suzuki H., and Mizutani S. Brap2 functions as a cytoplasmic retention protein for p21 during monocyte differentiation. Mol. Cell. Biol. 24 (2004) 8236-8243
75. Fineberg K., Fineberg T., Graessmann A., Luedtke N.W., Tor Y., Lixin R., Jans D.A., and Loyter A. Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules. Biochemistry (Mosc.) 42 (2003) 2625-2633
76. Efthymiadis A., Briggs L.J., and Jans D.A. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. J. Biol. Chem. 273 (1998) 1623-1628
77. Forwood J.K., and Jans D.A. Nuclear import pathway of the telomere elongation suppressor TRF1: inhibition by importin alpha. Biochemistry (Mosc.) 41 (2002) 9333-9340
78. Xiao C.Y., Hubner S., and Jans D.A. SV40 large tumor antigen nuclear import is regulated by the double-stranded DNA-dependent protein kinase site (serine 120) flanking the nuclear localization sequence. J. Biol. Chem. 272 (1997) 22191-22198
79. Briggs L.J., Stein D., Goltz J., Corrigan V.C., Efthymiadis A., Hubner S., and Jans D.A. The cAMP-dependent protein kinase site (Ser312) enhances dorsal nuclear import through facilitating nuclear localization sequence/importin interaction. J. Biol. Chem. 273 (1998) 22745-22752
80. Gilmore T.D., and Temin H.M. v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J. Virol. 62 (1988) 703-714
81. Lixin R., Efthymiadis A., Henderson B., and Jans D.A. Novel properties of the nucleolar targeting signal of human angiogenin. Biochem. Biophys. Res. Commun. 284 (2001) 185-193
82. Briggs L.J., Johnstone R.W., Elliot R.M., Xiao C.Y., Dawson M., Trapani J.A., and Jans D.A. Novel properties of the protein kinase CK2-site-regulated nuclear-localization sequence of the interferon-induced nuclear factor IFI 16. Biochem. J. 353 (2001) 69-77
83. Dohner K., Nagel C.H., and Sodeik B. Viral stop-and-go along microtubules: taking a ride with dynein and kinesins. Trends Microbiol. 13 (2005) 320-327
84. Greber U.F., and Way M. A superhighway to virus infection. Cell 124 (2006) 741-754
85. Dauty E., and Verkman A.S. Actin cytoskeleton as the principal determinant of size-dependent DNA mobility in cytoplasm: a new barrier for non-viral gene delivery. J. Biol. Chem. 280 (2005) 7823-7828
86. Welte M.A. Bidirectional transport along microtubules. Curr. Biol. 14 (2004) R525-R537
87. Mastrobattista E., van der Aa M.A., Hennink W.E., and Crommelin D.J. Artificial viruses: a nanotechnological approach to gene delivery. Nat. Rev. Drug Discov. 5 (2006) 115-121
88. Hansen J., Qing K., and Srivastava A. Infection of purified nuclei by adeno-associated virus 2. Mol. Ther.: J. Am. Soc. Gene Ther. 4 (2001) 289-296
89. Keminer O., and Peters R. Permeability of single nuclear pores. Biophys. J. 77 (1999) 217-228
90. Paine P.L., Moore L.C., and Horowitz S.B. Nuclear envelope permeability. Nature 254 (1975) 109-114
91. Stewart M. Molecular mechanism of the nuclear protein import cycle. Nat. Rev., Mol. Cell Biol. 8 (2007) 195-208
92. Burke B. Cell biology. Nuclear pore complex models gel. [comment]. Science 314 (2006) 766-767
93. Peters R. Translocation through the nuclear pore complex: selectivity and speed by reduction-of-dimensionality. Traffic 6 (2005) 421-427
94. Stoffler D., Schwarz-Herion K., Aebi U., and Fahrenkrog B. Getting across the nuclear pore complex: new insights into nucleocytoplasmic transport. Can. J. Physiol. Pharm. 84 (2006) 499-507
95. Frey S., Richter R.P., and Gorlich D. FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties. [see comment]. Science 314 (2006) 815-817
96. Naim B., Brumfeld V., Kapon R., Kiss V., Nevo R., and Reich Z. Passive and facilitated transport in nuclear pore complexes is largely uncoupled. J. Biol. Chem. 282 (2007) 3881-3888
97. Pante N., and Kann M. Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol. Biol. Cell 13 (2002) 425-434
98. Lim R.Y., and Fahrenkrog B. The nuclear pore complex up close. Curr. Opin. Cell Biol. 18 (2006) 342-347
99. Chan C.K., Senden T., and Jans D.A. Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modified polylysines. Gene Ther. 7 (2000) 1690-1697
100. Gundersen G.G., and Cook T.A. Microtubules and signal transduction. Curr. Opin. Cell Biol. 11 (1999) 81-94
101. Goodson H.V., Valetti C., and Kreis T.E. Motors and membrane traffic. Curr. Opin. Cell Biol. 9 (1997) 18-28
102. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 279 (1998) 519-526
103. Karcher R.L., Deacon S.W., and Gelfand V.I. Motor-cargo interactions: the key to transport specificity. Trends Cell Biol. 12 (2002) 21-27
104. Rogers S.L., and Gelfand V.I. Membrane trafficking, organelle transport, and the cytoskeleton. Curr. Opin. Cell Biol. 12 (2000) 57-62
105. Taunton J. Actin filament nucleation by endosomes, lysosomes and secretory vesicles. Curr. Opin. Cell Biol. 13 (2001) 85-91
106. Pantaloni D., Le Clainche C., and Carlier M.F. Mechanism of actin-based motility. [erratum appears in Science 2001 Jun 15;292(5524):2012]. Science 292 (2001) 1502-1506
107. Mooseker M.S., and Cheney R.E. Unconventional myosins. Ann. Rev. Cell Dev. Biol. 11 (1995) 633-675
108. Euteneuer U., and McIntosh J.R. Structural polarity of kinetochore microtubules in PtK1 cells. J. Cell Biol. 89 (1981) 338-345
109. Malki S., Berta P., Poulat F., and Boizet-Bonhoure B. Cytoplasmic retention of the sex-determining factor SOX9 via the microtubule network. Exp. Cell Res. 309 (2005) 468-475
110. Giannakakou P., Sackett D.L., Ward Y., Webster K.R., Blagosklonny M.V., and Fojo T. p53 is associated with cellular microtubules and is transported to the nucleus by dynein. [see comment]. Nat. Cell Biol. 2 (2000) 709-717
111. Lam M.H., Thomas R.J., Loveland K.L., Schilders S., Gu M., Martin T.J., Gillespie M.T., and Jans D.A. Nuclear transport of parathyroid hormone (PTH)-related protein is dependent on microtubules. Mol. Endocrinol. 16 (2002) 390-401
112. Jans D.A., Ackermann M.J., Bischoff J.R., Beach D.H., and Peters R. p34cdc2-mediated phosphorylation at T124 inhibits nuclear import of SV-40T antigen proteins. J. Cell Biol. 115 (1991) 1203-1212
113. Ribbeck K., and Gorlich D. The permeability barrier of nuclear pore complexes appears to operate via hydrophobic exclusion. EMBO J. 21 (2002) 2664-2671
114. Seydel U., and Jans D.A. Evidence for an inhibitory feedback loop regulating simian virus 40 large T-antigen fusion protein nuclear transport. Biochem. J. 315 (1996) 33-39
115. Giannakakou P., Nakano M., Nicolaou K.C., O'Brate A., Yu J., Blagosklonny M.V., Greber U.F., and Fojo T. Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10855-10860
116. Galigniana M.D., Harrell J.M., O'Hagen H.M., Ljungman M., and Pratt W.B. Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. J. Biol. Chem. 279 (2004) 22483-22489
117. Lo K.W., Kan H.M., Chan L.N., Xu W.G., Wang K.P., Wu Z., Sheng M., and Zhang M. The 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulation. J. Biol. Chem. 280 (2005) 8172-8179
118. Efthymiadis A., Shao H., Hubner S., and Jans D.A. Kinetic characterization of the human retinoblastoma protein bipartite nuclear localization sequence (NLS) in vivo and in vitro. A comparison with the SV40 large T-antigen NLS. J. Biol. Chem. 272 (1997) 22134-22139
119. Liang S.H., and Clarke M.F. A bipartite nuclear localization signal is required for p53 nuclear import regulated by a carboxyl-terminal domain. J. Biol. Chem. 274 (1999) 32699-32703
120. Lam M.H., Hu W., Xiao C.Y., Gillespie M.T., and Jans D.A. Molecular dissection of the importin beta1-recognized nuclear targeting signal of parathyroid hormone-related protein. Biochem. Biophys. Res. Commun. 282 (2001) 629-634
121. Henderson J.E., Amizuka N., Warshawsky H., Biasotto D., Lanske B.M., Goltzman D., and Karaplis A.C. Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol. Cell. Biol. 15 (1995) 4064-4075
122. Markiewicz E., Dechat T., Foisner R., Quinlan R.A., and Hutchison C.J. Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein. Mol. Biol. Cell 13 (2002) 4401-4413
123. Massfelder T., Dann P., Wu T.L., Vasavada R., Helwig J.J., and Stewart A.F. Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13630-13635
124. Mittnacht S., and Weinberg R.A. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65 (1991) 381-393
125. Templeton D.J. Nuclear binding of purified retinoblastoma gene product is determined by cell cycle-regulated phosphorylation. Mol. Cell. Biol. 12 (1992) 435-443
126. Tovar Sepulveda V.A., Shen X., and Falzon M. Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. Endocrinology 143 (2002) 596-606
127. Zacksenhaus E., Bremner R., Phillips R.A., and Gallie B.L. A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol. Cell. Biol. 13 (1993) 4588-4599
128. Silver P.A., Keegan L.P., and Ptashine M. Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 5951-5955
129. Fominaya J., and Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J. Biol. Chem. 271 (1996) 10560-10568
130. Mesika A., Grigoreva I., Zohar M., and Reich Z. A regulated, NFkappaB-assisted import of plasmid DNA into mammalian cell nuclei. Mol. Ther.: J. Am. Soc. Gene Ther. 3 (2001) 653-657
131. Mesika A., Kiss V., Brumfeld V., Ghosh G., and Reich Z. Enhanced intracellular mobility and nuclear accumulation of DNA plasmids associated with a karyophilic protein. Hum. Gene Ther. 16 (2005) 200-208
132. Baxevanis A.D., and Landsman D. The HMG-1 box protein family: classification and functional relationships. Nucleic Acids Res. 23 (1995) 1604-1613
133. Escriou V., Carriere M., Scherman D., and Wils P. NLS bioconjugates for targeting therapeutic genes to the nucleus. Adv. Drug Deliv. Rev. 55 (2003) 295-306
134. Bottger M., Vogel F., Platzer M., Kiessling U., Grade K., and Strauss M. Condensation of vector DNA by the chromosomal protein HMG1 results in efficient transfection. Biochim. Biophys. Acta 950 (1988) 221-228
135. Isaka Y., Akagi Y., Kaneda Y., and Imai E. The HVJ liposome method. Exp. Nephrol. 6 (1998) 144-147
136. Kaneda Y., Iwai K., and Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243 (1989) 375-378
137. Namiki Y., Takahashi T., and Ohno T. Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: cationic liposomal gene therapy of carcinomatosa. Gene Ther. 5 (1998) 240-246
138. Bottger M., Zaitsev S.V., Otto A., Haberland A., and Vorob'ev V.I. Acid nuclear extracts as mediators of gene transfer and expression. Biochim. Biophys. Acta 1395 (1998) 78-87
139. Zaitsev S.V., Haberland A., Otto A., Vorob'ev V.I., Haller H., and Bottger M. H1 and HMG17 extracted from calf thymus nuclei are efficient DNA carriers in gene transfer. Gene Ther. 4 (1997) 586-592
140. Kornberg R.D., and Lorch Y. Chromatin structure and transcription. Annu. Rev. Cell Biol. 8 (1992) 563-587
141. Baake M., Doenecke D., and Albig W. Characterisation of nuclear localisation signals of the four human core histones. J. Cell. Biochem. 81 (2001) 333-346
142. Baake M., Bauerle M., Doenecke D., and Albig W. Core histones and linker histones are imported into the nucleus by different pathways. Eur. J. Cell Biol. 80 (2001) 669-677
143. Mosammaparast N., Jackson K.R., Guo Y., Brame C.J., Shabanowitz J., Hunt D.F., and Pemberton L.F. Nuclear import of histone H2A and H2B is mediated by a network of karyopherins. J. Cell Biol. 153 (2001) 251-262
144. Wagstaff K.M., and Jans D.A. Protein Transduction: Cell Penetrating Peptides and Their Therapeutic Applications. Curr. Med. Chem. 13 (2006) 1371-1387
145. Kaouass M., Beaulieu R., and Balicki D. Histonefection: novel and potent non-viral gene delivery. J. Control. Release 113 (2006) 245-254
146. In: Knipe D.M., et al. (Ed). Field's Virology. 5th edition (2007), Lippincott, Williams & Wilkins 1-3177
147. Whittaker G.R., Kann M., and Helenius A. Viral entry into the nucleus. Annu. Rev. Cell Dev. Biol. 16 (2000) 627-651
148. Whittaker G.R. Virus nuclear import. Adv. Drug Deliv. Rev. 55 (2003) 733-747
149. Greber U.F., and Fassati A. Nuclear import of viral DNA genomes. Traffic 4 (2003) 136-143
150. Strunze S., Trotman L.C., Boucke K., and Greber U.F. Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export. Mol. Biol. Cell 16 (2005) 2999-3009
151. Trotman L.C., Mosberger N., Fornerod M., Stidwill R.P., and Greber U.F. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat. Cell Biol. 3 (2001) 1092-1100
152. Greber U.F., Suomalainen M., Stidwill R.P., Boucke K., Ebersold M.W., and Helenius A. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J. 16 (1997) 5998-6007
153. Batterson W., Furlong D., and Roizman B. Molecular genetics of herpes simplex virus. VIII. further characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of the viral reproductive cycle. J. Virol. 45 (1983) 397-407
154. Sodeik B., Ebersold M.W., and Helenius A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136 (1997) 1007-1021
155. Dasgupta A., and Wilson D.W. ATP depletion blocks herpes simplex virus DNA packaging and capsid maturation. J. Virol. 73 (1999) 2006-2015
156. Ojala P.M., Sodeik B., Ebersold M.W., Kutay U., and Helenius A. Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol. Cell Biol. 20 (2000) 4922-4931
157. Kann M., Bischof A., and Gerlich W.H. In vitro model for the nuclear transport of the hepadnavirus genome. J. Virol. 71 (1997) 1310-1316
158. Kann M., Sodeik B., Vlachou A., Gerlich W.H., and Helenius A. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J. Cell Biol. 145 (1999) 45-55
159. Kemler I., Whittaker G., and Helenius A. Nuclear import of microinjected influenza virus ribonucleoproteins. Virology 202 (1994) 1028-1033
160. Martin K., and Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J. Virol. 65 (1991) 232-244
161. Bukrinsky M.I., Sharova N., Dempsey M.P., Stanwick T.L., Bukrinskaya A.G., Haggerty S., and Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6580-6584
162. Subbramanian R.A., Kessous-Elbaz A., Lodge R., Forget J., Yao X.J., Bergeron D., and Cohen E.A. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J. Exp. Med. 187 (1998) 1103-1111
163. Bouyac-Bertoia M., Dvorin J.D., Fouchier R.A., Jenkins Y., Meyer B.E., Wu L.I., Emerman M., and Malim M.H. HIV-1 infection requires a functional integrase NLS. Mol. Cell 7 (2001) 1025-1035
164. Limon A., Devroe E., Lu R., Ghory H.Z., Silver P.A., and Engelman A. Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import. J. Virol. 76 (2002) 10598-10607
165. Clever J., Yamada M., and Kasamatsu H. Import of simian virus 40 virions through nuclear pore complexes. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 7333-7337
166. Yamada M., and Kasamatsu H. Role of nuclear pore complex in simian virus 40 nuclear targeting. J. Virol. 67 (1993) 119-130
167. Chapman M.S., and Rossmann M.G. Structure, sequence, and function correlations among parvoviruses. Virology 194 (1993) 491-508
168. Vihinen-Ranta M., Kakkola L., Kalela A., Vilja P., and Vuento M. Characterization of a nuclear localization signal of canine parvovirus capsid proteins. Eur. J. Biochem. 250 (1997) 389-394
169. Vihinen-Ranta M., Wang D., Weichert W.S., and Parrish C.R. The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J. Virol. 76 (2002) 1884-1891
170. Matthews D.A., and Russell W.C. Adenovirus core protein V is delivered by the invading virus to the nucleus of the infected cell and later in infection is associated with nucleoli. J. Gen. Virol. 79 Pt 7 (1998) 1671-1675
171. Lee T.W., Blair G.E., and Matthews D.A. Adenovirus core protein VII contains distinct sequences that mediate targeting to the nucleus and nucleolus, and colocalization with human chromosomes. J. Gen. Virol. 84 (2003) 3423-3428
172. Wodrich H., Cassany A., D'Angelo M.A., Guan T., Nemerow G., and Gerace L. Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways. J. Virol. 80 (2006) 9608-9618
173. Vayda M.E., Rogers A.E., and Flint S.J. The structure of nucleoprotein cores released from adenovirions. Nucleic Acids Res. 11 (1983) 441-460
174. Green M., and Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55 (1988) 1179-1188
175. Joliot A., Pernelle C., Deagostini-Bazin H., and Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 1864-1868
176. Frankel A.D., and Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 (1988) 1189-1193
177. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 (1994) 10444-10450
178. Elliott G., and O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88 (1997) 223-233
179. Mae M., and Langel U. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr. Opin. Pharmacol. 6 (2006) 509-514
180. Murriel C.L., and Dowdy S.F. Influence of protein transduction domains on intracellular delivery of macromolecules. Expert Opin. Drug Deliv. 3 (2006) 739-746
181. White P.J., Fogarty R.D., McKean S.C., Venables D.J., Werther G.A., and Wraight C.J. Oligonucleotide uptake in cultured keratinocytes: influence of confluence, cationic liposomes, and keratinocyte cell type. J. Invest. Dermatol. 112 (1999) 699-705
182. Sirsi S.R., Williams J.H., and Lutz G.J. Poly(ethylene imine)-poly(ethylene glycol) copolymers facilitate efficient delivery of antisense oligonucleotides to nuclei of mature muscle cells of mdx mice. Hum. Gene Ther. 16 (2005) 1307-1317
183. Panyutin I.V., Sedelnikova O.A., Bonner W.M., Panyutin I.G., and Neumann R.D. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei. Ann. N.Y. Acad. Sci. 1058 (2005) 140-150
184. De Mesmaeker A., Altmann K.H., Waldner A., and Wendeborn S. Backbone modifications in oligonucleotides and peptide nucleic acid systems. Curr. Opin. Struct. Biol. 5 (1995) 343-355
185. Micklefield J. Backbone modification of nucleic acids: synthesis, structure and therapeutic applications. Curr. Med. Chem. 8 (2001) 1157-1179
186. Pouton C.W. Nuclear import of polypeptides, polynucleotides and supramolecular complexes. Adv. Drug Deliv. Rev. 34 (1998) 51-64
187. Munkonge F.M., Dean D.A., Hillery E., Griesenbach U., and Alton E.W. Emerging significance of plasmid DNA nuclear import in gene therapy. Adv. Drug Deliv. Rev. 55 (2003) 749-760
188. Collas P., and Alestrom P. Nuclear localization signal of SV40 T antigen directs import of plasmid DNA into sea urchin male pronuclei in vitro. Mol. Reprod. Dev. 45 (1996) 431-438
189. Collas P., and Alestrom P. Rapid targeting of plasmid DNA to zebrafish embryo nuclei by the nuclear localization signal of SV40 T antigen. Mol. Mar. Biol. Biotechnol. 6 (1997) 48-58
190. Collas P., and Alestrom P. Nuclear localization signals: a driving force for nuclear transport of plasmid DNA in zebrafish. Biochem. Cell. Biol. 75 (1997) 633-640
191. Collas P., Husebye H., and Alestrom P. The nuclear localization sequence of the SV40 T antigen promotes transgene uptake and expression in zebrafish embryo nuclei. Transgenic Res. 5 (1996) 451-458
192. Aronsohn A.I., and Hughes J.A. Nuclear localization signal peptides enhance cationic liposome-mediated gene therapy. J. Drug Target. 5 (1998) 163-169
193. Bremner K.H., Seymour L.W., and Pouton C.W. Harnessing nuclear localization pathways for transgene delivery. Curr. Opin. Mol. Ther. 3 (2001) 170-177
194. Bremner K.H., Seymour L.W., Logan A., and Read M.L. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconjug. Chem. 15 (2004) 152-161
195. Keller M., Harbottle R.P., Perouzel E., Colin M., Shah I., Rahim A., Vaysse L., Bergau A., Moritz S., Brahimi-Horn C., Coutelle C., and Miller A.D. Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems. Chem. Bio. Chem. 4 (2003) 286-298
196. Zabner J., Fasbender A.J., Moninger T., Poellinger K.A., and Welsh M.J. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270 (1995) 18997-19007
197. Brunner S., Sauer T., Carotta S., Cotten M., Saltik M., and Wagner E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. 7 (2000) 401-407
198. Sebestyen M.G., Ludtke J.J., Bassik M.C., Zhang G., Budker V., Lukhtanov E.A., Hagstrom J.E., and Wolff J.A. DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA. Nat. Biotechnol. 16 (1998) 80-85
199. Zanta M.A., Belguise-Valladier P., and Behr J.P. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 91-96
200. Tanimoto M., Kamiya H., Minakawa N., Matsuda A., and Harashima H. No enhancement of nuclear entry by direct conjugation of a nuclear localization signal peptide to linearized DNA. Bioconjug. Chem. 14 (2003) 1197-1202
201. Nagasaki T., Myohoji T., Tachibana T., Futaki S., and Tamagaki S. Can nuclear localization signals enhance nuclear localization of plasmid DNA?. Bioconjug. Chem. 14 (2003) 282-286
202. Carriere M., Escriou V., Savarin A., and Scherman D. Coupling of importin beta binding peptide on plasmid DNA: transfection efficiency is increased by modification of lipoplex's physico-chemical properties. BMC Biotechnol. 3 (2003) 14
203. van der Aa M.A., Koning G.A., d'Oliveira C., Oosting R.S., Wilschut K.J., Hennink W.E., and Crommelin D.J. An NLS peptide covalently linked to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems. J. Gene Med. 7 (2005) 208-217
204. van der Aa M., Koning G., van der Gugten J., d'Oliveira C., Oosting R., Hennink W.E., and Crommelin D.J. Covalent attachment of an NLS-peptide to linear dna does not enhance transfection efficiency of cationic polymer based gene delivery systems. J. Control. Release 101 (2005) 395-397
205. Ciolina C., Byk G., Blanche F., Thuillier V., Scherman D., and Wils P. Coupling of nuclear localization signals to plasmid DNA and specific interaction of the conjugates with importin alpha. Bioconjug. Chem. 10 (1999) 49-55
206. Neves C., Byk G., Scherman D., and Wils P. Coupling of a targeting peptide to plasmid DNA by covalent triple helix formation. FEBS Lett. 453 (1999) 41-45
207. Roulon T., Helene C., and Escude C. Coupling of a targeting peptide to plasmid DNA using a new type of padlock oligonucleotide. Bioconjug. Chem. 13 (2002) 1134-1139
208. Branden L.J., Mohamed A.J., and Smith C.I. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotechnol. 17 (1999) 784-787
209. Dean D.A. Peptide nucleic acids: versatile tools for gene therapy strategies. Adv. Drug Deliv. Rev. 44 (2000) 81-95
210. Carlisle R.C., Bettinger T., Ogris M., Hale S., Mautner V., and Seymour L.W. Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors. Molec. Ther. 4 (2001) 473-483
211. Benimetskaya L., Guzzo-Pernell N., Liu S.T., Lai J.C., Miller P., and Stein C.A. Protamine-fragment peptides fused to an SV40 nuclear localization signal deliver oligonucleotides that produce antisense effects in prostate and bladder carcinoma cells. Bioconjug. Chem. 13 (2002) 177-187
212. Akita H., Tanimoto M., Masuda T., Kogure K., Hama S., Ninomiya K., Futaki S., and Harashima H. Evaluation of the nuclear delivery and intra-nuclear transcription of plasmid DNA condensed with micro (mu) and NLS-micro by cytoplasmic and nuclear microinjection: a comparative study with poly-L-lysine. J. Gene Med. 8 (2006) 198-206
213. Wagstaff K.M., and Jans D.A. Intramolecular masking of nuclear localization signals: analysis of importin binding using a novel AlphaScreen-based method. Anal. Biochem. 348 (2006) 49-56
214. Dean D.A., Dean B.S., Muller S., and Smith L.C. Sequence requirements for plasmid nuclear import. Exp. Cell Res. 253 (1999) 713-722
215. Vacik J., Dean B.S., Zimmer W.E., and Dean D.A. Cell-specific nuclear import of plasmid DNA. Gene Ther. 6 (1999) 1006-1014
216. Dean D.A., Strong D.D., and Zimmer W.E. Nuclear entry of nonviral vectors. Gene Ther. 12 (2005) 881-890
217. Lechardeur D., Sohn K.J., Haardt M., Joshi P.B., Monck M., Graham R.W., Beatty B., Squire J., O'Brodovich H., and Lukacs G.L. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. 6 (1999) 482-497
218. Lechardeur D., and Lukacs G.L. Nucleocytoplasmic transport of plasmid DNA: a perilous journey from the cytoplasm to the nucleus. Hum. Gene Ther. 17 (2006) 882-889
219. Vaysse L., Harbottle R., Bigger B., Bergau A., Tolmachov O., and Coutelle C. Development of a self-assembling nuclear targeting vector system based on the tetracycline repressor protein. J. Biol.Chem. 279 (2004) 5555-5564
220. Ludtke J.J., Zhang G., Sebestyen M.G., and Wolff J.A. A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J. Cell Sci. 112 Pt 12 (1999) 2033-2041
221. Wels W., Biburger M., Muller T., Dalken B., Giesubel U., Tonn T., and Uherek C. Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors. Cancer Immunol. Immunother. 53 (2004) 217-226
222. Pastan I., Hassan R., FitzGerald D.J., and Kreitman R.J. Immunotoxin treatment of cancer. Annu. Rev. Med. 58 (2007) 221-237
223. Fominaya J., and Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system. J. Biol. Chem. 271 (1996) 10560-10568
224. Uherek C., Fominaya J., and Wels W. A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery. J. Biol. Chem. 273 (1998) 8835-8841
225. Uherek C., and Wels W. DNA-carrier proteins for targeted gene delivery. Adv. Drug Deliv. Rev. 44 (2000) 153-166
226. Pouton C.W., and Seymour L.W. Key issues in non-viral gene delivery. Adv. Drug Deliv. Rev 34 (1998) 3-19
227. Schirmbeck R., Konig-Merediz S.A., Riedl P., Kwissa M., Sack F., Schroff M., Junghans C., Reimann J., and Wittig B. Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide. J. Mol. Med. 79 (2001) 343-350
228. Riedl P., Reimann J., and Schiirmbeck R. Complexes of DNA vaccines with cationic, antigenic peptides are potent, polyvalent CD8(+) T-cell-stimulating immunogens. Methods Mol. Med. 127 (2006) 159-169
229. van Gaal E.V., Hennink W.E., Crommelin D.J., and Mastrobattista E. Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy. Pharm. Res. 23 (2006) 1053-1074
230. Ivics Z., Hackett P.B., Plasterk R.H., and Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91 (1997) 501-510
231. Ivics Z., Katzer A., Stuwe E.E., Fiedler D., Knespel S., and Izsvak Z. Targeted sleeping beauty transposition in human cells. Molec. Ther. 15 (2007) 1137-1144
232. Wu S.C., Meir Y.J., Coates C.J., Handler A.M., Pelczar P., Moisyadi S., and Kaminski J.M. piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15008-15013